| License: Creative Commons Attribution Non-commercial No Derivatives 4.0 PDF - Published Version (652kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-445932
- DOI to cite this document:
- 10.5283/epub.44593
This publication is part of the DEAL contract with Wiley.
Abstract
BACKGROUND Extracorporeal photopheresis (ECP) is an immunosuppressive treatment that involves leukocyte apheresis, psoralen and UV light treatment, and subsequent reinfusion. Patients treated with ECP are usually immunosuppressed. Bacterial contamination therefore poses a much unwanted risk, but incidence data are lacking. PATIENTS AND METHODS We screened all 1922 consecutive ECP procedures ...
Owner only: item control page
Download Statistics